SWOT Analysis for Entrada Therapeutics Inc

Value Stocks, Under Radar (DVM)
Significant (over 30%) distance from 52 week high
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Affordable Stocks - Stocks with Good Trendlyne Valuation Score
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Stock with Low PE (PE < = 10)

Stocks with Quarter Change % less than Industry
New 52 week low today
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Oversold by Money Flow Index (MFI)
Highest fall from 52 Week High
Top Losers
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Near 52 Week Low
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter